Clinical Trials · NCT00412022
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- National Cancer Institute, Naples
- Enrollment
- 1,294
- Start date
- Mar 2004
- Locations
- 20 sites, Italy
- Primary endpoint
- disease free survival in premenopausal patients